Additionally, an inverse dose-dependent association was found in HeFH subjects with LDL receptor (LDLR) negative mutations who had a lower T2DM prevalence than carriers of defective LDLR or apolipoprotein B mutations [26]. This evidence concerns the gene APOB and type 2 diabetes mellitus.